SCHEMBL6581243

SCHEMBL6581243

CCc1c(N)cc(C)c2nc[nH]c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 2/20 0.36
▸ NOS2 P35228 2/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ ACP1 P24666 1/20 0.34
▸ PDPK1 O15530 1/20 0.33
▸ CDK1 P06493 5/20 0.33
▸ CCNB1 P14635 5/20 0.33
▸ CCNA2 P20248 5/20 0.33
▸ CDK2 P24941 5/20 0.33
▸ CCNA1 P78396 5/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ CSNK2A2 P19784 2/20 0.32
▸ CSNK2A1 P68400 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ CSNK2B P67870 1/20 0.32
▸ KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6581235 0.87 NOS2 (0.40) NOS3NOS2PARP1KDM4EALDH1A1
SCHEMBL6142566 0.79 PARP1 (0.40) PARP1KDM4EALDH1A1PDPK1MAPT
SCHEMBL7033875 0.76 MEN1 (0.50) PARP1KDM4EALDH1A1PDPK1MAPT
SCHEMBL6581434 0.73 ALDH1A1 (0.32) PARP1ALDH1A1
SCHEMBL6581844 0.73 PARP1 (0.34) PARP1PDPK1
SCHEMBL6142564 0.72 PDPK1 (0.37) PARP1KDM4EALDH1A1PDPK1MAPT
SCHEMBL15629821 0.70 NOS3 (0.40) NOS3NOS2PARP1ALDH1A1PDPK1
SCHEMBL6976286 0.69 PRKCI (0.38) NOS3NOS2PARP1KDM4EALDH1A1
SCHEMBL7033872 0.69 MEN1 (0.50) PARP1KDM4EALDH1A1PDPK1MAPT
SCHEMBL6876629 0.67 PARP1 (0.42) PARP1ACP1PDPK1CSNK2A2CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037887-B1 5-(2-IMIDAZOLINYLAMINO)-BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS .ALPHA.-ADRENOCEPTOR AGONISTS WITH IMPROVED METABOLIC STABILITY PROCTER & GAMBLE (US) 2004-07-14 — — EP disclosed
US-6486190-B1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability THE PROCTER & GAMBLE COMPANY 2002-11-26 — — US disclosed
EP-1037887-A1 5-(2-IMIDAZOLINYLAMINO)-BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS .ALPHA.-ADRENOCEPTOR AGONISTS WITH IMPROVED METABOLIC STABILITY THE PROCTER & GAMBLE COMPANY (US) 2000-09-27 — — EP disclosed
WO-1999026942-A1 5-(2-IMIDAZOLINYLAMINO)-BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS .ALPHA.-ADRENOCEPTOR AGONISTS WITH IMPROVED METABOLIC STABILITY THE PROCTER & GAMBLE COMPANY (US) 1999-06-03 — — WO disclosed
Send feedback